Onconetix – since formally dropping its once-hot pursuit of a universal flu vaccine in December 2023 – has tried to make ...

A new stroke thrombolytic — tenecteplase — marketed as TNKase — has received FDA approval, marking the first such advancement in nearly 30 years. Unlike alteplase (tPA), which requires a lengthy ...

In this video, Raj Chovatiya, MD, PhD, discussed continued research on rocatinlumab in the ROCKET HORIZON Trial.